Using exome data from Alzheimer's disease cases and controls with or without the APOE4 risk allele, investigators identified potential risk-stratifying variants.
A study of more than 10,000 women showed cancer predisposition genes confer similar risks of breast cancer in African-American women as in whites.
Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form.
The long-running Framingham Heart Study has received a $38 million grant, according to the Boston Globe.
In Nature this week: durum wheat genome assembly, approach for analyzing joint genetic architecture of complex traits, and more.
Researchers have linked gene variants to chronic traumatic encephalopathy severity, CBS News reports.
Conducting studies on Latina and African-American women produces population-specific insights on the genetics of the disease that aren't possible to glean in European-heavy GWAS.
The company is hoping that consumers will use its platform to manage their health data, to participate in research, and to learn about their own and their family's health risks.
The researchers found that the expression of certain genes was better at helping them predict when Ebola would develop than indications of infection like fever.
Newly launched aggregator Seqster will help Boston University researchers collect data from EHRs, wearables, and gene tests to identify concussion biomarkers.
Holden Thorp is to be the new editor-in-chief of Science and its related journals.
A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.
Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.
In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.